Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant

Susan K. Parsons, Angie Mae Rodday, Ruth Ann Weidner, Erin Morris, Suzanne Braniecki, Shalini Shenoy, Julie An Talano, Theodore B. Moore, Anne Panarella, Allyson Flower, Jordan Milner, Sandra Fabricatore, Harshini Mahanti, Carmella van de Ven, Qiuhu Shi, Mitchell S. Cairo

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Allogeneic stem cell transplantation (AlloSCT) represents the only curative therapy for sickle cell disease (SCD). However, limited availability of matched related donors and suboptimal outcomes following AlloSCT with unrelated donors has led to investigation of alternative donors. Among children with high-risk SCD, we evaluated health-related quality of life (HRQoL) impact in the two years following familial haploidentical SCT. HRQoL was collected from parent and child raters, using the Child Health Ratings Inventories Generic measure and haploidentical SCT-specific module. Repeated measures models were fit to assess HRQoL changes over time and by rater. Nineteen children (mean age 12.9 yrs [standard deviation, 5.3]; 63% male) and their parents were included. There were no differences in the 2-yr trajectories of child physical or emotional functioning (EF) by rater. Child physical functioning and EF scores were significantly lower at day +45 than baseline, but scores recovered by day +180. There was significant improvement in EF (p = 0.03) at 2 yrs vs baseline. A similar pattern of scores over time was seen for parent ratings of child’s global HRQoL. Despite treatment intensity in the initial months following AlloSCT, patient scores recovered or exceeded baseline scores at two years. This trial is registered at (NCT01461837).

Original languageEnglish
Pages (from-to)586-592
Number of pages7
JournalBone Marrow Transplantation
Issue number4
StatePublished - Apr 2022


Dive into the research topics of 'Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant'. Together they form a unique fingerprint.

Cite this